The Latest Cardiac and Vascular News
MONMOUTH JUNCTION, N.J., May 2, 2022 /PRNewswire/ — CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery using blood purification, announced that the Company has been awarded a new preferred supplier agreement for CytoSorb® with the Asklepios Group (Asklepios), one of the largest private […]
– Patients successfully self-managed PSVT episodes with etripamil which reduced need for ED intervention – – As in other studies, etripamil was well tolerated by patients – – Data to be featured during late breaking session at Heart Rhythm 2022 – MONTREAL and CHARLOTTE, N.C., April 30, 2022 /PRNewswire/ — Milestone Pharmaceuticals Inc. (Nasdaq: MIST), […]
SALT LAKE CITY, May 2, 2022 /PRNewswire/ — Biomerics, a leading vertically integrated contract manufacturer for the attractive interventional device market, announced the creation of a new division, Biomerics Image Guided Intervention (IGI). Biomerics’ IGI Division, headquartered in Salt Lake City, provides advanced image generation and processing technologies to enable real-time minimally invasive […]
JERUSALEM, May 2, 2022 /PRNewswire/ — VOTIS Subdermal Imaging Technologies Ltd. announced today that it has enrolled the first patient in the feasibility study of its PedCheckTM device at Hadassah Medical Center in Jerusalem, Israel. The pilot study, entitled “The Use of Hemodynamic Occlusive Vascular Response (HOVR™) technology to Screen for Peripheral Arterial Disease (PAD)”, is intended to […]
New investment will progress treatment of pulmonary arterial hypertension (PAH), a rare condition which causes high blood pressure in the blood vessels that supply the lungs and can lead to heart failure. Current approved medications mainly address the symptoms of this rare condition. This novel approach aims to address the […]
Analysis of open-label extension data demonstrated that bempedoic acid was generally well tolerated and demonstrated sustained efficacy with up to 2.5 years of continuous treatment May 02, 2022 08:00 ET | Source: Esperion Therapeutics, Inc. ANN ARBOR, Mich., May 02, 2022 (GLOBE NEWSWIRE) — Esperion (NASDAQ: ESPR) today announced the publication of data […]
Study Presented at the International Society for Heart and Lung Transplant 42nd Annual Meeting and Scientific Sessions 2022 Oak Ridge, TN, May 02, 2022 (GLOBE NEWSWIRE) — Daxor Corporation (Nasdaq: DXR), the global leader in blood volume measurement technology, announces new data validating the benefits of the Company’s BVA-100 blood test (BVA) in improving […]
SEOUL, South Korea–(BUSINESS WIRE)–NEXEL, a global leader in induced pluripotent stem cell (iPSC) technology, announced today that it has achieved ISO/IEC 17025:2017 quality standard for laboratory testing, the world’s most respected quality management standard, by the Korea Laboratory Accreditation Scheme(KOLAS). KOLAS is a signatory of the International Laboratory Accreditation Cooperation […]
The Financing round was led by growth equity firm Stripes, and marks Hello Heart’s leadership in cardiovascular digital therapeutics and proven ability to close gaps in heart health – the number one cause of death in the U.S. MENLO PARK, Calif.–(BUSINESS WIRE)–Hello Heart, the only digital therapeutic that focuses on […]
On Its Anniversary, the Inventor of Measure-through Motion and Low Perfusion™ Pulse Oximetry Introduces the First Health Watch to Offer Accurate, Continuous Measurements IRVINE, Calif.–(BUSINESS WIRE)–Masimo (NASDAQ: MASI) marks its 33rd anniversary today by announcing the limited market release of the W1™ health watch for consumers. The first of its kind, the […]
